|
|
|
|
|
|
|
|
Featured Media Release GlaxoSmithKline (GSK) Australia will implement changes to the Product Information (PI) for products containing rosiglitazone (Avandia) and rosiglitazone/metformin (Avandamet). Patients taking Avandia or Avandamet should make an appointment with their doctor to review their treatment as soon as possible. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Media Releases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| © 2006 GlaxoSmithKline Australia Pty Ltd - All Rights Reserved |
|